Agilent Technologies, Inc.
Rank #266HypergrowthA · NYSE · Healthcare
Agilent Technologies, Inc. (A) — Rank #266 by gross profitability (GP/assets 0.26) · ROE 17.7% · Piotroski F-Score 8 / 9.
As-of 2026-09-15 · CIK 0001090872 · all metrics point-in-time as of the filing date.
About
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
Show moreShow less
The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and other custom services. This segment also offers consumables, including gas chromatography and liquid chromatography columns, sample preparation products, custom chemistries, and various laboratory supplies; software and informatics solutions comprising software for instrument control, data acquisition, data analysis, secure storage of results, and laboratory information and workflow management; and OpenLab laboratory software, an open software platform that enables customers to capture, analyze, and share scientific data throughout the lab and across the enterprise. In addition, it provides automated sample preparation solutions, such as liquid handling, plate management, consumables, and scheduling software. The Applied Markets segment offers products in the areas of gas chromatography, mass spectrometry, spectroscopy, vacuum technology, and remarketed instruments. It markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc.
was incorporated in 1999 and is headquartered in Santa Clara, California.
- Industry
- Diagnostics & Research
- Sector
- Healthcare
- State
- DE
- Filer Category
- Large accelerated filer
- Fiscal Year End
- October 31
- Website
- agilent.com
Financials
Stable
Direction over 5 fiscal years
- Free cash flowimproving
- Gross marginstable
- Gross profitabilitystable
- Net cashimproving
- Operating marginimproving
- Return on equityimproving
- Share count (dilution)improving
Red flags: fcf_ni_divergence_unfavorable — rating capped at Stable
Monitoring diagnostic of business direction — not a prediction of returns.
Each fiscal year is read as-of that year’s own 10-K filing, so nothing restated after the fact leaks backwards. Line items this filer never tagged are omitted. Hover or tap a badge for the diagnostic behind it.
| Fiscal year end | 2017-10-31filed 2017-12-21 | 2016-10-31filed 2016-12-20 | 2015-10-31filed 2015-12-21 | 2014-10-31filed 2015-12-21 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | 4,472.0 | 4,202.0 | 4,038.0 | 4,048.0 |
| Revenue growth (YoY) | 6.4% | 4.1% | -0.2% | -0.2% |
| Gross profit | 2,409.0 | 2,197.0 | 2,041.0 | 2,041.0 |
| Gross margin | 53.9% | 52.3% | 50.5% | 50.5% |
| Net income | 684.0 | 462.0 | 401.0 | 549.0 |
| Net margin | 15.3% | 11.0% | 9.9% | 9.9% |
| EPS (diluted) | $2.10 | $1.40 | $1.20 | $1.62 |
| EPS growth (YoY) | 50.0% | 16.7% | -25.9% | — |
| Cash flow | ||||
| Operating cash flow | 889.0 | 793.0 | 491.0 | 711.0 |
| Capital expenditures | 176.0 | 139.0 | 98.0 | — |
| Free cash flow | 713.0 | 654.0 | 393.0 | 393.0 |
Figures are as originally filed with the SEC (point-in-time), not restated, so they can differ slightly from sites that show later-restated numbers. Why point-in-time?